Ryan Specialty Holdings, Inc.
NYSE:RYANInsurance - Specialty
-$0.59 today
- Market cap
- $5.79B
- Beta
- 0.64
- P/E (TTM)
- 34.2
- EPS (TTM)
- $1.02
- Dividend yield
- 1.44%
Volume 1.38M
Average 2.89M
RYAN Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Ryan Specialty Holdings, Inc.NYSE: RYAN
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables falls 86.1% from a year ago
Net receivables stood at $697.56M at the end of Q2 FY2026, down 86.1% from a year earlier and up 23.4% from the prior quarter. Over 3 fiscal years it compounded at -44.6% a year.
Context
- Net receivables amounted to 5.8% of total assets at the end of Q2 FY2026, down 41.5 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -86.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 488.95M USD
- Year-over-year change
- -88.3%
- 4-year CAGR
- -34.2%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 488.95M | -88.3% |
| FY2024 | 2024-12-31 | 4.17B | +20.5% |
| FY2023 | 2023-12-31 | 3.46B | +20.6% |
| FY2022 | 2022-12-31 | 2.87B | +10.3% |
| FY2021 | 2021-12-31 | 2.6B | — |
Net Receivables vs competitors
How RYAN compares with its peers on the latest reported figures
- RYAN's Jun 2026 net receivables of $697.56M is the 5th highest of the 9 companies compared; the peer median is $920.26M.
- Its year-over-year change of -86.1% is the 7th highest of 9, against a peer median of -12.5%.
- Net receivables amounts to 5.8% of total assets for RYAN, versus a peer median of 4.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $28.39B | -4.0% | +11.2% | 6.6% | |
| Jun 2026 | $20.28B | +6.1% | -12.9% | 23.8% | |
| Jun 2026 | $8.27B | -40.6% | +5.0% | 15.0% | |
| Sep 2026 | $1.56B | +234.5% | +3.6% | 8.7% | |
| Jun 2026 | $697.56M | -86.1% | -44.6% | 5.8% | |
| Sep 2026 | $278.32M | -21.1% | +5.2% | 0.5% | |
| Sep 2026 | $186.99M | +93.4% | +19.8% | 2.5% | |
| Sep 2026 | $0 | -100.0% | -28.5% | 0.0% | |
| Jun 2026 | -$32M | -100.3% | -4.8% | 0.0% | |
| Peer median (excluding RYAN) | $920.26M | -12.5% | +4.3% | 4.5% | |
Competitors are the stored peer set for RYAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 386.96M | 992.72M | 838.79M | 540.2M | 158.32M |
| Short-term Investments | 0 | 0 | 0 | 13.94M | 0 |
| Net Receivables | 2.6B | 2.87B | 3.46B | 4.17B | 488.95M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | (76.55M) |
| Total Current Assets | 3.04B | 3.91B | 4.35B | 4.81B | 647.27M |
| Property, Plant & Equipment (Net) | 100.16M | 175.14M | 170.14M | 183.47M | 199.94M |
| Goodwill | 1.31B | 1.31B | 1.65B | 2.65B | 3.23B |
| Intangible Assets | 573.93M | 486.44M | 610.67M | 1.48B | 119.62M |
| Long-term Investments | 45.42M | 38.51M | 46.1M | 70.88M | 109.98M |
| Tax Assets | 382.75M | 396.81M | 383.82M | 448.29M | 310.14M |
| Other Non-current Assets | 10.79M | 56.99M | 39.31M | 18.59M | 5.95B |
| Total Non-current Assets | 2.42B | 2.47B | 2.9B | 4.84B | 9.92B |
| Total Assets | 5.46B | 6.38B | 7.25B | 9.65B | 10.56B |
| Account Payables | 0 | 0 | 0 | 0 | 217.3M |
| Short-term Debt | 23.47M | 30.59M | 35.38M | 51.73M | 60.19M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 631K | 562K | 55K | 39.92M | (217.3M) |
| Total Current Liabilities | 433.56M | 414.31M | 501.28M | 649.45M | 86.17M |
| Long-term Debt | 1.57B | 1.95B | 1.94B | 3.23B | 3.29B |
| Deferred Tax Liabilities | 631K | 562K | 55K | 39.92M | 49.83M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.79B | 3.05B | 3.67B | 4.47B | 5.73B |
| Total Non-current Liabilities | 4.43B | 5.15B | 5.77B | 7.9B | 9.22B |
| Total Liabilities | 4.86B | 5.57B | 6.27B | 8.55B | 9.31B |
| Common Stock | 259K | 259K | 261K | 261K | 265K |
| Retained Earnings | (7.06M) | 53.99M | 114.42M | 122.94M | 120.35M |
| Accumulated OCI | 1.71M | 6.04M | 3.08M | (1.8M) | 13.85M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 251M | 339.41M | 419.89M | 470.62M | 605.98M |
| Total Equity | 594.78M | 817.81M | 979.64M | 1.1B | 1.25B |
| Total Debt | 1.68B | 2.16B | 2.16B | 3.46B | 3.53B |
| Net Debt | 1.3B | 1.16B | 1.32B | 2.92B | 3.37B |
Ryan Specialty Holdings, Inc.
NYSE:RYAN
Intrinsic Alpha fair value
Locked
Current Price
$48.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.